Search

everythinglearnresearchcommunity

for

Search:↓

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

The CRH/CRH-R1 system might be involved in causing lichen planus.

Eating a balanced diet with the right vitamins and minerals is important for healthy hair, but too many supplements can be harmful.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

People with alopecia areata have similar retinal structures but thicker choroidal regions compared to those without the condition.

Animal models are crucial for learning about hair loss and finding treatments.

People in Jeddah know about Vitamin D and its sources but are unclear on how much they need daily, and while many women take supplements, attitudes towards increasing Vitamin D levels vary.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Genetic testing is crucial before giving azathioprine to avoid severe side effects.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Blocking LFA-1 prevents hair loss in mice.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

AKN is a chronic scalp condition in African-descended males, treated with topicals, antibiotics, steroids, and sometimes surgery or laser.

Heat treatment increases hair loss in certain mice.

The Chinese herbal supplement BeauTop can potentially boost hair growth and thickness by increasing a protein called Vascular Endothelial Growth Factor.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Apremilast did not work for treating severe alopecia areata.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Human hair follicles have a unique way of using energy and might use the Cori cycle; blocking CCR5 could help treat hair loss.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

Liquid nitrogen cryotherapy and betamethasone lotion are equally effective for treating alopecia areata.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.